IMMUNOTECH-B: RESIGNATION OF CHIEF FINANCIAL OFFICER,COMPANY SECRETARY AND AUTHORISED REPRESENTATIVEANDAPPOINTMENT OF JOINT COMPANY SECRETARIES ANDAUTHORISED REPRESENTATIVE ANDWAIVER FROM STRICT COMPLIANCEWITH RULES 3.28 AND 8.17 OF THE LISTING RULES
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
IMMUNOTECH-B: DISCLOSEABLE TRANSACTIONDISPOSAL OF THE CERTIFICATES OF DEPOSITS
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
IMMUNOTECH-B: FOURTH AMENDED AND RESTATEDMEMORANDUM AND ARTICLES OF ASSOCIATION
IMMUNOTECH-B: POLL RESULTS OF THE ANNUAL GENERAL MEETINGHELD ON 24 MAY 2024
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
IMMUNOTECH-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON 24 MAY 2024
IMMUNOTECH-B: NOTICE OF ANNUAL GENERAL MEETING
IMMUNOTECH-B: PROPOSED RE-ELECTION OF RETIRING DIRECTORS,PROPOSED GRANTING OF GENERAL MANDATES TOISSUE SHARES AND REPURCHASE SHARES,PROPOSED AMENDMENTS TO THE EXISTINGMEMORANDUM AND ARTICLES OF ASSOCIATIONAND ADOPTION OF THE FOURTH MEMORANDUM ANDARTICLES OF ASSOCI
IMMUNOTECH-B: 2023 ANNUAL REPORT
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
IMMUNOTECH-B: PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM ANDARTICLES OF ASSOCIATION AND ADOPTION OFTHE FOURTH MEMORANDUM AND ARTICLES OF ASSOCIATION
IMMUNOTECH-B: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED 31 DECEMBER 2023
IMMUNOTECH-B: DATE OF BOARD MEETING
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
IMMUNOTECH-B: VOLUNTARY ANNOUNCEMENTTHE CLINICAL TRIAL APPROVAL FOR THE aT19 INJECTION
IMMUNOTECH-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
IMMUNOTECH-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
IMMUNOTECH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
No Data